2016
The clinical and molecular epidemiology of pre‐transplant vancomycin‐resistant enterococci colonization among liver transplant recipients
Banach DB, Peaper DR, Fortune BE, Emre S, Dembry LM. The clinical and molecular epidemiology of pre‐transplant vancomycin‐resistant enterococci colonization among liver transplant recipients. Clinical Transplantation 2016, 30: 306-311. PMID: 26780305, DOI: 10.1111/ctr.12690.Peer-Reviewed Original ResearchConceptsLiver transplant recipientsLiver transplantationVRE colonizationTransplant recipientsVancomycin-resistant enterococci (VRE) infectionPolymerase chain reaction testingVancomycin-resistant enterococci colonizationPre-transplant colonizationSubsequent liver transplantationMore hospital daysObservational cohort studyCentral venous catheterizationInfection prevention measuresWarrants further studyRifaximin useAntimicrobial prophylaxisCohort studyHospital daysSignificant morbidityVenous catheterizationProspective studyActive surveillanceRisk factorsSurveillance culturesVRE isolates
2014
Clinical and Molecular Epidemiology of Pretransplant Vancomycin-Resistant Enterococci (VRE) Colonization Among Patients Who Undergo Liver Transplantation.
Banach D, Peaper D, Emre S, Fortune B, Dembry L. Clinical and Molecular Epidemiology of Pretransplant Vancomycin-Resistant Enterococci (VRE) Colonization Among Patients Who Undergo Liver Transplantation. Transplantation 2014, 98: 769. DOI: 10.1097/00007890-201407151-02627.Peer-Reviewed Original ResearchVancomycin-resistant enterococci colonizationLiver transplantationMolecular epidemiologyPatientsTransplantationEpidemiology
2005
Approaches to vancomycin-resistant enterococci
Torres-Viera C, Dembry L. Approaches to vancomycin-resistant enterococci. Current Opinion In Internal Medicine 2005, 4: 6-12. DOI: 10.1097/00132980-200502000-00003.Peer-Reviewed Original ResearchVancomycin-resistant enterococciVancomycin-resistant enterococci colonizationNew drugsSerious enterococcal infectionsLimited clinical dataInfection control practicesVitro bactericidal activityPurpose of reviewLipopeptide antimicrobialBloodstream infectionsClinical trialsEnterococcal infectionsOral administrationClinical dataInfectionAntimicrobial drugsBactericidal activityPhase IIDrugsEnterococciTreatmentNew antimicrobial drugsStrict guidelinesTrialsControl practices
2004
Approaches to vancomycin-resistant enterococci
Torres-Viera C, Dembry LM. Approaches to vancomycin-resistant enterococci. Current Opinion In Infectious Diseases 2004, 17: 541-547. PMID: 15640708, DOI: 10.1097/00001432-200412000-00006.Peer-Reviewed Original ResearchConceptsVancomycin-resistant enterococciVancomycin-resistant enterococci colonizationNew drugsSerious enterococcal infectionsLimited clinical dataInfection control practicesVitro bactericidal activityLipopeptide antimicrobialBloodstream infectionsClinical trialsEnterococcal infectionsOral administrationClinical dataInfectionAntimicrobial drugsBactericidal activityPhase IIDrugsEnterococciTreatmentNew antimicrobial drugsStrict guidelinesTrialsControl practicesBacterial isolates